Target intelligence / Profile preview

Dermal papilla cell-derived exosome

Molecular classification
Extracellular vesicle, MicroRNA, Growth factor, Other
01

Overview

This entry describes the complex signaling network mediated by dermal papilla cell (DPC)-derived exosomes in the hair follicle microenvironment. These exosomes function as paracrine messengers, transporting a cargo of microRNAs and growth factors that regulate the activity of neighboring cells, such as hair matrix cells and outer root sheath cells (Hu et al., 2020, Bioactive Materials). Key signaling pathways involved in this process include the Wnt/β-catenin, Sonic Hedgehog (Shh), and Bone Morphogenetic Protein (BMP) pathways, which are critical for hair follicle morphogenesis and cycling (Zhou et al., 2018, Journal of Dermatological Science). Specifically, exosomal miRNAs like miR-218-5p have been shown to promote the transition from the telogen (resting) phase to the anagen (growth) phase by stabilizing β-catenin. In conditions such as androgenetic alopecia, the secretion and composition of these exosomes are often altered, contributing to the miniaturization of the hair follicle. Therapeutic approaches targeting these pathways involve the use of exogenous exosomes or the delivery of specific exosomal components to restore healthy signaling (Kwack et al., 2019, Journal of Investigative Dermatology). While not a single molecular target, this system represents a significant area of research in regenerative medicine for hair loss. Current challenges include the standardization of exosome isolation, characterization of the bioactive cargo, and ensuring long-term safety in clinical applications.

Other names
DPC-derived exosomeDPC-ExoMultiple intracellular and paracrine pathways in hair follicle cells via exosome-delivered RNAs and growth factors
02

Mechanism of action

Activation of Wnt/β-catenin and Shh signaling pathways via exosomal delivery of miRNAs and growth factors to stimulate hair follicle regeneration.

03

Biological functions

Signal transductionCell proliferationParacrine signalingOther
04

Disease associations

Other
05

Safety considerations

Immunogenicity of allogeneic exosomesPotential for oncogenic transformation if Wnt is over-activatedStandardization of exosome isolation and cargo characterization
06

Interacting drugs

Minoxidil

2 more in the full profile.

07

Biomarkers

miR-218-5pβ-cateninVEGF

Beyond the preview

Go deeper on Dermal papilla cell-derived exosome.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dermal papilla cell-derived exosome.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call